SCHEMBL5838115

SCHEMBL5838115

CCCCc1ccc(C)c(C)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SKP2 Q13309 1/20 0.68
▸ HPGD P15428 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ CYP3A4 P08684 4/20 0.51
▸ CYP2D6 P10635 2/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ CYP4Z1 Q86W10 1/20 0.51
▸ CYP4F11 Q9HBI6 1/20 0.51
▸ CYP4F12 Q9HCS2 1/20 0.51
▸ CA2 P00918 2/20 0.45
▸ CA1 P00915 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17866573 0.93 SKP2 (0.60) SKP2CYP3A4CYP2D6CYP2C9CYP1A2
SCHEMBL10608353 0.91 SKP2 (0.58) SKP2CYP3A4ALDH1A1HSD17B10ESR1
SCHEMBL9298886 0.91 SKP2 (0.58) SKP2CYP3A4ALDH1A1HSD17B10ESR1
SCHEMBL598650 0.86 CNR1 (0.50) SKP2CYP3A4CYP2D6CYP2C9CYP1A2
SCHEMBL31556195 0.86 SKP2 (0.50) SKP2CYP3A4ALDH1A1HSD17B10ESR1
SCHEMBL311370 0.83 PTGS1 (0.45) SKP2NPC1HTTRAB9ACYP3A4
SCHEMBL29597103 0.83 PTGS1 (0.45) SKP2NPC1HTTRAB9ACYP3A4
SCHEMBL29380988 0.83 PTGS1 (0.45) SKP2NPC1HTTRAB9ACYP3A4
SCHEMBL11366320 0.83 SKP2 (0.58) SKP2HPGDNPC1MAPK1HTT
Hydrochloric Acid SCHEMBL2446312 0.82 SKP2 (0.47) SKP2CYP3A4CYP2D6CYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-61022985-A — — None — — JP disclosed
CN-101157707-A Metallic compound, catalytic component for addition polymerization, catalyst for addition polymerization and method for producing addition polymer SUMITOMO CHEMICAL CO (JP) 2008-04-09 — — CN disclosed
CN-1307213-C Catalyst component for polyaddition, catalyst and method for producing addition polymer SUMITOMO CHEMICAL CO (JP) 2007-03-28 — — CN disclosed
CN-1303108-C Contact product, catalytic component and addition polymerizing cathlyst and method for producing addition polymer SUMITOMO CHEMICAL CO (JP) 2007-03-07 — — CN disclosed
US-7030285-B2 Alkylation process OPTATECH CORPORATION (FI) 2006-04-18 — — US disclosed
EP-1250300-B1 ALKYLATION PROCESS OPTATECH CORP (FI) 2004-12-15 — — EP disclosed
CN-1532209-A Contact product, catalytic component and addition polymerizing cathlyst and method for producing addition polymer 住友化学工业株式会社 2004-09-29 — — CN disclosed
CN-1530378-A Catalyst component for polyaddition, catalyst and method for producing addition polymer ס�ѻ�ѧ��ҵ��ʽ���� 2004-09-22 — — CN disclosed
CN-1163522-C Olefine polymerization catalyst and method for production of olefine polymer using it 住友化学工业株式会社 2004-08-25 — — CN disclosed
CN-1517368-A Metal compound, catalyst component and catalyst for addition polymerization, and process for producing addition polymer ס�ѻ�ѧ��ҵ��ʽ���� 2004-08-04 — — CN disclosed
US-20030023124-A1 Alkylation process OPTATECH CORPORATION (FI) 2003-01-30 — — US disclosed
EP-1250300-A1 ALKYLATION PROCESS Optatech Corporation (FI) 2002-10-23 — — EP disclosed
WO-2001055061-A1 ALKYLATION PROCESS OPTATECH CORPORATION (FI) 2001-08-02 — — WO disclosed
CN-1286271-A Olefine polymerization catalyst and method for production of olefine polymer using it SUMITOMO CHEMICAL CO (JP) 2001-03-07 — — CN disclosed
JP-S6122985-A SOLVENT FOR PRESSURE-SENSITIVE REPRODUCTION PAPER TOA NENRYO KOGYO KK 1986-01-31 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030023124-A1 Alkylation process MGMT, DNMT3A, TET2 SKP2 389/4885HPGD 4808/4885NPC1 3078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback